Anti-NRR1 antibody is a Human of Fab class that binds to an NRR1. It developed From human phage antibody libraries with synthetic diversities in the selected complementary determining regions (H1, H2, H3, L3), mimicking the natural diversity of the human IgG repertoire.
Figure 1 Anti-NRR1 is an anti-angiogenic agent that inhibits tumour growth.
a, Mouse neonate retinal assay for endothelial cell sprouting and angiogenesis. Retinal vasculature from mouse neonates treated with the indicated antibodies was visualized following isolectin perfusion. Top panels, scale bar 51mm. Bottom panels, scale bar 50.2mm.
Wu, Y., Cain-Hom, C., Choy, L., Hagenbeek, T. J., de Leon, G. P., Chen, Y., ... & Schahin-Reed, D. (2010). Therapeutic antibody targeting of individual Notch receptors. Nature, 464(7291), 1052.
Figure 2 Selective antibody blocking of Notch1 or Notch2 avoids severe goblet cell metaplasia associated with pan-Notch inhibition.
Immunohistochemical analyses of small intestines, using Alcian blue for mucin to mark secretory goblet cells, anti-Ki-67 staining for proliferation, anti-Hes1 staining for expression of a Notch pathway target, and lysozyme for Paneth cells.
Wu, Y., Cain-Hom, C., Choy, L., Hagenbeek, T. J., de Leon, G. P., Chen, Y., ... & Schahin-Reed, D. (2010). Therapeutic antibody targeting of individual Notch receptors. Nature, 464(7291), 1052.
Figure 3 Anti-NRR1 function as receptor-specific inhibitors in vivo.
Thymus or spleen cells frommice treated with the indicated reagents were harvested for flow cytometry ofCD41/CD81 T cells.
Wu, Y., Cain-Hom, C., Choy, L., Hagenbeek, T. J., de Leon, G. P., Chen, Y., ... & Schahin-Reed, D. (2010). Therapeutic antibody targeting of individual Notch receptors. Nature, 464(7291), 1052.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-H11 | Anti-Human NOTCH1 Recombinant Antibody (Brontictuzumab) | Inhib | IgG2 - lambda |
TAB-541MZ | Human Anti-NOTCH1 Recombinant Antibody (TAB-541MZ) | Neut, WB | Humanized antibody |
TAB-542MZ | Human Anti-NOTCH1 Recombinant Antibody (TAB-542MZ) | Neut, WB | Humanized antibody |
TAB-544MZ | Anti-Human NOTCH1 Recombinant Antibody (A12.2) | ELISA, FuncS, Inhib | Humanized antibody |
TAB-541MZ-F(E) | Human Anti-NOTCH1 Recombinant Antibody; Fab Fragment (TAB-541MZ-F(E)) | WB, Competition ELISA | Humanized Fab |
There are currently no Customer reviews or questions for PABX-152-F (E). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.